|
|
|
|
Relapses in anti-NMDAR encephalitis are common (24%). They may occur many years after the initial episode. Relapses may present with aspects or with isolated symptoms of the full-blown syndrome. Immunotherapy at first episode reduces the risk of relapses. |
|